All updates
All updates
today 33监管与产业动态精选评分4141 监管与产业动态评分3737 Insmed seeking CFO, plus C-suite additions for Iovance, Vir
监管与产业动态评分3636 TRex Bio stomps toward $111M IPO, as Retension and Lycia also gear up to go public - Fierce Biotech
监管与产业动态评分2929 BD commits $19B amid US onshoring push, with $3B earmarked for manufacturing growth - Fierce Pharma
监管与产业动态评分5050 Forbion’s ‘landmark’ €2.3B fundraise to benefit 30 ‘high potential’ biotechs - Fierce Biotech
监管与产业动态评分1919 Genentech celebrates 50 years of 'The Impossible Bet' in anniversary documentary - Fierce Pharma
监管与产业动态评分11 Retension Pharmaceuticals - Fierce Biotech
监管与产业动态评分1818 Big Pharma-backed Nuvig halts development of lead fusion protein in rare autoimmune disease - Fierce Biotech
中文产业新闻Chinese source评分6060 礼来追加8.7亿美元扩大与Gate Biosciences的分子闸门口服药合作
中文产业新闻Chinese source评分5959 罗氏引进 Alector 临床前帕金森病 GCase 酶替代疗法 AL050，总额 12.7 亿美元
BioPharma Dive精选评分6060 Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds
中文产业新闻Chinese source评分6060 Alector与基因泰克达成12.7亿美元全球独家许可，引进临床前帕金森病新药AL050
中文产业新闻Chinese source评分5050 8.7亿美元！礼来再次押注分子门药物
中文产业新闻Chinese source评分6363 GE HealthCare 以 9.45 亿美元现金收购 PET 放射性药物 CDMO 公司 SOFIE Biosciences
中文产业新闻Chinese source评分3939 艾博生物与诺华就ABO2203及RNA平台达成合作
中文产业新闻Chinese source评分6363 Alector与基因泰克就两个临床阶段抗体达成授权合作
中文产业新闻Chinese source评分2626 从150家杀出15家！Fierce Biotech揭晓2026年度Fierce 15榜单
中文产业新闻Chinese source评分6060 盐野义制药拟以20亿美元首付款收购IntraBio全部已发行股份
BioSpace评分6767 Shionogi makes $2B rare disease play with IntraBio buy
中文产业新闻Chinese source评分6666 盐野义20亿美元收购IntraBio获NPC药物AQNEURSA，2025年销售6787万美元
STAT News评分3737 STAT+: AstraZeneca opens new Boston site
BioSpace精选评分4646 Compliance concerns hinder rollout of AI in drug manufacturing: Survey
监管与产业动态评分2424 Signal or noise? > RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing - businesswire.com >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #pharma #competitivemarketing
BioPharma Dive精选评分6666 GE HealthCare to acquire Sofie Biosciences for $945M
监管与产业动态精选评分7272 Building again in rare diseases, Shionogi pays $2B for IntraBio
监管与产业动态精选评分6464 CSL buys into Alentis’ lead autoimmune program for $355M: Deals Report
监管与产业动态评分2525 China deals, Beam lawsuit, MFN models, Nobel winners — a BioCentury podcast
监管与产业动态评分3333 Fierce Biotech Fundraising Tracker '26: KymaThera corrals $80M; RougeTx lifts off with $58M - Fierce Biotech
监管与产业动态评分4747 CSL pays $355M to co-develop Alentis’ phase 2-stage fibrosis drug - Fierce Biotech
监管与产业动态评分2121 Meet Motivista: Click Therapeutics debuts first-of-its-kind schizophrenia digital therapeutic - Fierce Biotech
监管与产业动态评分1616 Introducing Fierce Biotech's 2026 Fierce 15 - Fierce Biotech
监管与产业动态精选评分4242 Gate CEO sees expanded $870M pact with Lilly as ‘vote of confidence’ in biotech’s platform - Fierce Biotech
监管与产业动态评分1818 BridgeBio taps Hip Hop Public Health and others up to put a new beat on ATTR-CM awareness - Fierce Pharma
监管与产业动态评分4242 Genentech pays Alector $100M for preclinical Parkinson’s prospect - Fierce Biotech
监管与产业动态评分4242 Shionogi strikes $2B deal for IntraBio hot off FDA label expansion - Fierce Pharma
监管与产业动态评分33 Gate Bioscience - Fierce Biotech
监管与产业动态评分1717 Gilead partners with Calm to roll out disease-specific emotional wellness support - Fierce Pharma
BioSpace评分2626 BioSpace 40 Under 40 winners make their mark on biopharma
中文产业新闻精选Chinese source评分6262 基因泰克从 Alector 引进临床前帕金森管线 AL050，首付款 1 亿美元
中文产业新闻Chinese source评分5656 盐野义拟20亿美元收购IntraBio